Opioid Conversion Calculator

Opioid conversion works through a common currency, the morphine milligram equivalent, which restates any opioid dose as the amount of oral morphine expected to give comparable analgesia. Standard factors put oral oxycodone at 1.5, oral hydromorphone at 4, oral hydrocodone at 1, codeine at 0.15 and tramadol at 0.1, with parenteral morphine at 3 because oral bioavailability is only about a third. Transdermal fentanyl is handled per microgram per hour rather than per milligram, at roughly 2.4, so a 25 microgram/hour patch approximates 60 mg of oral morphine daily. The calculated equivalent is then cut by 25 to 50 percent before prescribing. That reduction is not a safety margin bolted on for caution; it corrects for incomplete cross-tolerance, since tolerance to one agonist does not transfer fully to another at the same receptor, so a numerically equal dose of the new drug can behave as an overdose. Methadone breaks the arithmetic entirely. Its potency relative to morphine rises with the dose converted, from about 2 to 1 at low equivalents to 12 or 15 to 1 above several hundred milligrams daily, and its half-life ranges from 8 to 59 hours, so accumulation and respiratory depression can appear days after an apparently uneventful start, and it also prolongs the QT interval. Individual variation in CYP2D6 and CYP3A4 activity adds further error, notably for codeine and tramadol, which are prodrugs. The CDC uses 50 and 90 MME per day as thresholds for heightened caution and reassessment, and breakthrough dosing is conventionally 10 to 20 percent of the new daily total.

The equianalgesic table has its roots in the analgesic assay methods developed at Memorial Sloan Kettering Cancer Center in New York from the 1950s, where Raymond Houde, Stanley Wallenstein and William Beaver established controlled crossover techniques for comparing the potency of opioids against a morphine standard in patients with cancer pain. Those relative potency ratios, published across the 1960s and 1970s, became the numbers that still populate conversion charts today, which is why the tables carry an inheritance of small sample sizes and single-dose designs. The drugs themselves arrived from varied origins: methadone was synthesised in Germany in the late 1930s at the Hoechst laboratories, and fentanyl was created by Paul Janssen in Belgium in 1960. The concept of a single aggregated morphine equivalent moved from palliative care into population-level policy during the North American opioid crisis. The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, authored by Deborah Dowell, Tamara Haegerich and Roger Chou, published a standard conversion table and the 50 and 90 MME per day thresholds, which were rapidly adopted by insurers, prescription monitoring programmes and state legislation. That rigid application produced harm through abrupt tapering of stable patients, and the 2022 revision explicitly withdrew the thresholds as hard limits and cautioned against applying them inflexibly. Opioid rotation practice, described in clinical guidance by Fine and Portenoy among others, has meanwhile settled on conservative reduction plus close titration rather than reliance on any table.